Raymond James Financial’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.05M Sell
27,934
-542
-2% -$51.7K ﹤0.01% 3006
2025
Q4
$2.31M Buy
28,476
+1,164
+4% +$100K ﹤0.01% 3156
2025
Q3
$2.39M Buy
27,312
+521
+2% +$46.5K ﹤0.01% 3035
2025
Q2
$2.22M Sell
26,791
-47,045
-64% -$3.93M ﹤0.01% 2994
2025
Q1
$6.19M Sell
73,836
-87,872
-54% -$8.17M ﹤0.01% 2187
2024
Q4
$14.9M Buy
+161,708
New +$15.6M 0.01% 1523

Other funds holding LMAT

Raymond James Financial's LMAT Position: Q1 2026 in Review

Raymond James Financial reduced its LeMaitre Vascular (LMAT) stake by 1.9% in Q1 2026, selling an estimated $51.7K and leaving 27,934 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3006.

Raymond James Financial first reported a position in LMAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.9M in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Raymond James Financial held 27,934 shares of LeMaitre Vascular worth $3.05M as of Q1 2026.
  • Raymond James Financial sold 542 LeMaitre Vascular shares in Q1 2026, an estimated $51.7K.
  • LeMaitre Vascular made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3006 holding.
  • Raymond James Financial first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's LeMaitre Vascular position peaked at $14.9M in Q4 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.